 | Atara Biotherapeutics (NASDAQ:ATRA) Receives "Buy" Rating from William Blair
marketbeat.com - September 24 at 6:07 AM |
| Atara Biotherapeutics (NASDAQ:ATRA) Downgraded by Zacks Investment Research
marketbeat.com - August 11 at 5:34 PM |
 | Atara Biotherapeutics (NASDAQ:ATRA) Stock Price Up 5.1%
americanbankingnews.com - October 15 at 7:21 PM |
 | We Think Atara Biotherapeutics (NASDAQ:ATRA) Needs To Drive Business Growth Carefully
finance.yahoo.com - September 22 at 7:37 AM |
| Stocks Showing Market Leadership: Atara Biotherapeutics Earns 92 RS Rating
finance.yahoo.com - September 16 at 12:42 PM |
 | Beyond Mesothelioma, Multiple Sclerosis Could Help Atara's Stock Soar Exponentially
msn.com - September 15 at 4:41 PM |
| Atara (ATRA) Looks Good: Stock Adds 5.1% in Session
finance.yahoo.com - September 14 at 10:50 AM |
| Company News for Sep 14, 2020
finance.yahoo.com - September 14 at 10:50 AM |
| Atara Biotherapeutics To Present Clinical Data in Epstein-Barr Virus-Driven (EBV+) Acquired & Primary Immunodeficiency Lymphoproliferative Diseases (AID-LPD and PID-LPD) from Tab-Cel® Expanded Access Program in e-Poster at ESMO 2020 Virtual Congress
finance.yahoo.com - September 14 at 9:20 AM |
| Atara Bio Rises After Multiple Sclerosis Drug Shows Sustained Improvement
finance.yahoo.com - September 13 at 8:58 AM |
|
 | Atara Biotherapeutics Announces All Progressive Multiple Sclerosis Patients with Sustained Disability Improvement at Six Months Confirmed Improvement at 12 Months in the Phase ...
businesswire.com - September 13 at 8:18 AM |
 | Atara Bio lead candidate shows sustained benefit in MS patients
seekingalpha.com - September 11 at 10:00 AM |
| Atara Biotherapeutics Announces All Progressive Multiple Sclerosis Patients with Sustained Disability Improvement at Six Months Confirmed Improvement at 12 Months in the Phase 1a Study of ATA188
finance.yahoo.com - September 11 at 10:00 AM |
| Is a Viable Treatment for Mesothelioma on the Horizon?
msn.com - September 9 at 12:33 PM |
| Atara Biotherapeutics Announces FDA Clearance of IND for ATA2271, a Next-Generation Autologous Mesothelin-Targeted CAR T with Novel PD1DNR and 1XX Technologies Combined to Treat Solid Tumors
finance.yahoo.com - September 8 at 8:15 AM |
| Atara Biotherapeutics to Present 12-Month Data from All Four Cohorts in the Phase 1a Study of ATA188 in Progressive Multiple Sclerosis at MSVirtual2020
finance.yahoo.com - September 1 at 7:45 AM |
| Did Hedge Funds Make The Right Call On Atara Biotherapeutics Inc (ATRA)
finance.yahoo.com - August 12 at 1:15 PM |
| Did Hedge Funds Make The Right Call On Atara Biotherapeutics Inc (ATRA) ?
finance.yahoo.com - August 12 at 10:19 AM |
 | Atara Biotherapeutics Inc (ATRA) Q2 2020 Earnings Call Transcript
nasdaq.com - August 6 at 3:47 PM |
| Atara Biotherapeutics, Inc. (ATRA) CEO Pascal Touchon on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 6 at 2:58 AM |
| Atara Biotherapeutics Announces Second Quarter 2020 Financial Results and Operational Progress
finance.yahoo.com - August 5 at 4:57 PM |
| Assessing An Investment In Atara Biotherapeutics
seekingalpha.com - August 4 at 2:50 PM |
| Why Atara Biotherapeutics (ATRA) Might Surprise This Earnings Season
finance.yahoo.com - August 4 at 9:43 AM |
| Atara Biotherapeutics to Announce Second Quarter 2020 Financial Results on Wednesday, August 5, 2020
finance.yahoo.com - July 29 at 5:36 PM |
| Atara Biotherapeutics (ATRA) Moves to Buy: Rationale Behind the Upgrade
finance.yahoo.com - July 21 at 1:41 PM |
| Atara Biotherapeutics Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - June 24 at 7:29 PM |
| Hedge Funds Have Never Been This Bullish On Atara Biotherapeutics Inc (ATRA)
finance.yahoo.com - June 23 at 11:51 PM |
| Is Atara Biotherapeutics (ATRA) Stock a Solid Choice Right Now?
finance.yahoo.com - June 23 at 1:51 PM |
|
| Atara up 4% on advancement of ATA188 in MS study
seekingalpha.com - June 17 at 12:49 PM |
| Atara Biotherapeutics Announces First Patient Enrolled in Randomized Placebo-Controlled Study of Allogeneic T-cell Therapy ATA188 in Progressive Forms of Multiple Sclerosis
finance.yahoo.com - June 17 at 9:38 AM |
| Atara Biotherapeutics Announces its 2020 Annual Meeting of Stockholders Will Be Held on June 16, 2020 in Virtual Format
finance.yahoo.com - June 5 at 6:20 PM |
| Atara Biotherapeutics to Participate at Two Upcoming Conferences
finance.yahoo.com - June 4 at 6:56 PM |
| Atara Bio prices $175.5M equity offering
seekingalpha.com - May 27 at 9:31 AM |
| Atara Biotherapeutics Announces Pricing of $175.5 Million Public Offering
finance.yahoo.com - May 27 at 9:31 AM |
| Atara Bio launches equity offering
seekingalpha.com - May 26 at 6:14 PM |
| Atara Biotherapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants
finance.yahoo.com - May 26 at 6:14 PM |
 | Should Atara Bio's Stock Volatility Consider Any Valuation at All on Multiple Sclerosis?
247wallst.com - May 26 at 1:14 PM |
| Atara Biotherapeutics Presents Data Demonstrating Safety & Sustained Disability Improvement at 12 Months with ATA188 in Patients with Progressive Multiple Sclerosis in Late ...
www.businesswire.com - May 26 at 8:14 AM |
| Atara Biotherapeutics Presents Data Demonstrating Safety & Sustained Disability Improvement at 12 Months with ATA188 in Patients with Progressive Multiple Sclerosis in Late-Breaking e-Poster at the 2020 European Academy of Neurology Virtual Congress
finance.yahoo.com - May 26 at 8:14 AM |
| Atara Bio (+11%) cell therapy shows promising action in MS study
seekingalpha.com - May 22 at 5:48 PM |
 | Thinking about buying stock in Atara Biotherapeutics, Anavex Life Sciences, Boxlight Corp, FuelCell Energy, or Upwork Inc?
www.prnewswire.com - May 21 at 10:11 AM |
| ATRA Abuzz, ATOS' COVID-19 Med Effective, INO And VXRT On Track
www.nasdaq.com - May 21 at 1:48 AM |
| Atara Biotherapeutics to Present Late-Breaking ATA188 Data in Progressive Multiple Sclerosis at 2020 European Academy of Neurology (EAN) Virtual Congress
finance.yahoo.com - May 19 at 9:25 AM |
| Atara Biotherapeutics (ATRA) Moves to Strong Buy: Rationale Behind the Upgrade
finance.yahoo.com - May 18 at 1:56 PM |
| Atara Biotherapeutics Announces Presentation of Late-Breaking Preclinical Data on ATA2271, a Next-Generation Autologous CAR T Immunotherapy Targeting Mesothelin, at the ...
www.businesswire.com - May 15 at 2:14 PM |
| Atara Biotherapeutics Announces Presentation of Late-Breaking Preclinical Data on ATA2271, a Next-Generation Autologous CAR T Immunotherapy Targeting Mesothelin, at the American Association for Cancer Research (AACR) Virtual Annual Meeting II 2020
finance.yahoo.com - May 15 at 2:14 PM |
| Why Atara Biotherapeutics (ATRA) Stock Might be a Great Pick
finance.yahoo.com - May 13 at 10:23 AM |
| Atara Biotherapeutics Announces Appointment of Cell & Gene Therapy Expert Maria Grazia Roncarolo, MD to Board of Directors
finance.yahoo.com - May 11 at 6:13 PM |
| Will Atara Biotherapeutics Continue to Surge Higher?
finance.yahoo.com - May 11 at 3:35 PM |
| Edited Transcript of ATRA earnings conference call or presentation 6-May-20 8:30pm GMT
finance.yahoo.com - May 7 at 3:21 PM |
| Atara Biotherapeutics Inc (ATRA) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 7 at 3:21 PM |
| Atara Biotherapeutics EPS beats by $0.23
seekingalpha.com - May 7 at 1:16 AM |
